Molecular Partners Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
CSBR | D | Champions Oncology, Inc. | -0.10 | |
MOLN | F | Molecular Partners AG | -11.23 |
Related Industries: Biotechnology
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
IWC | C | iShares Microcap ETF | 0.01 | |
VXF | C | Vanguard Extended Market ETF | 0.0 |
Compare ETFs
Date | Stock | Title |
---|---|---|
Apr 17 | CSBR | Will Champions Oncology (NASDAQ:CSBR) Spend Its Cash Wisely? |
Related Industries:
Biotechnology
- Molecular Partners
Molecular Partners AG is a clinical-stage biopharmaceutical company based in Zürich, Switzerland. The company is developing a new class of potent, specific and versatile small-protein therapies called DARPins, with potential clinical applications in a range of disease areas including oncology, immuno-oncology, ophthalmology, and immunology. Molecular Partners currently has two DARPin molecules in clinical development, and a broad pipeline of molecules in preclinical development.
Popular Now
Recent Comments
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
- TraderMike on Market Recap for Friday, March 8, 2024
- Don_Marat on Market Recap for Friday, March 8, 2024
From the Blog
Featured Articles